Biostax Corp. financial data

Location
Winter Park, FL
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2024 - 19 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.31% % -92%
Debt-to-equity -104% % -25%
Return On Assets -1139% % -109%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83,738,939 shares 0.14%
Common Stock, Shares, Outstanding 83,738,939 shares 0.17%
Common Stock, Value, Issued $8,374 USD 0.17%
Weighted Average Number of Shares Outstanding, Basic 83,698,396 shares 0.5%
Weighted Average Number of Shares Outstanding, Diluted 83,698,396 shares 0.5%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $140,047 USD -93%
Operating Income (Loss) $1,211,027 USD 21%
Nonoperating Income (Expense) $1,011,864 USD 53%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $2,222,891 USD 40%
Earnings Per Share, Basic 0 USD/shares -101%
Earnings Per Share, Diluted 0 USD/shares -101%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,451 USD -69%
Assets, Current $2,098 USD -94%
Assets $5,451 USD -99%
Accounts Payable, Current $1,255,584 USD -7.6%
Accrued Liabilities, Current $418,057 USD 207%
Liabilities, Current $5,308,193 USD 37%
Liabilities $5,308,193 USD 37%
Retained Earnings (Accumulated Deficit) $386,111,735 USD -0.58%
Stockholders' Equity Attributable to Parent $5,302,741 USD -71%
Liabilities and Equity $5,451 USD -99%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $33,311 USD 87%
Net Cash Provided by (Used in) Financing Activities $5,624 USD -96%
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 83,738,939 shares 0.17%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $27,687 USD 76%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Share-based Payment Arrangement, Expense $0 USD
Interest Expense $225,701 USD 431%